Conversely, Stewart and colleagues [119] reported that the injection of CD45-depleted serous OC cells (obtained from HGSOC patients) via IP, SRC, IB, or MFP route in NOD/SCID mice resulted in high tumour takes regardless of the transplantation route (> 70%). The gene discussed is PTPRC; the disease is neoplasm.